(Q36832976)

English

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study

scientific article published on November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

0 references

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

P Ravn

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

B Clemmesen

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

B J Riis

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

C Christiansen

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

527-533

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early postmenopausal diminution of forearm and spinal bone mineral density: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Can we improve compliance with long-term HRT?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Western blots of immune globulin preparations for intravenous use.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of skeletal disease in breast cancer with clodronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy x-ray absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900229-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S8756-3282(96)00229-3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36832976&oldid=1658243460"